1. The Role of Genetic Variants (rs869109213 and rs2070744) Of theeNOSGene andBglII in the α2Subunit of the α2β1Integrin Gene in Diabetic Retinopathy in a Tunisian Population
   Fatma Midani et al, 2019, Seminars in Ophthalmology CrossRef
2. Evaluación rápida de la ceguera evitable, incluida la retinopatía diabética, en Querétaro, México
   Ellery M. López-Star et al, 2018, Revista Mexicana de Oftalmología CrossRef
3. Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis
   Sebastian A. Medina-Ramirez et al, 2024, PLOS ONE CrossRef
4. Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration
   Inge Van Hove et al, 2021, Progress in Retinal and Eye Research CrossRef
5. Prevalence of diabetic retinopathy and its risk factors in rural patients with type 2 diabetes referring to Beijing Huairou Hospital, China
   Jing Wang et al, 2024, BMC Ophthalmology CrossRef
6. Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy
   Suzanne Broadgate et al, 2018, Acta Ophthalmologica CrossRef
7. Single nucleotide variants of receptor for advanced glycation end-products (AGER) gene: is it a new opening in the risk assessment of diabetic retinopathy?—a review
   Pragya Ahuja et al, 2022, Journal of Genetic Engineering and Biotechnology CrossRef
8. Risk Factors for Diabetic Retinopathy in Latin America (Mexico) and the World: A Systematic Review and Meta-Analysis
   Oscar Vivanco-Rojas et al, 2023, Journal of Clinical Medicine CrossRef